Professor of Clinical Translational Metabolism, Group Leader. #obesity University of Copenhagen @uni_copenhagen
København, Danmark
Joined February 2017
- Tweets179
- Following57
- Followers261
- Likes151
Signe S Torekov retweeted
👉SØG SØG DEL INDEN 18/8: Er du vores nye forskningskoordinator indenfor svær overvægtsforskning og behandling? jobportal.ku.dk/alle-opslag/… @BiomedUCPH @CTMetabUCPH @UCPH_Research
Signe S Torekov retweeted
Effects of 3 months of 10-h per-day time-restricted eating on bodyweight and cardiometabolic health in individuals at risk of type 2 diabetes: the RESET randomised controlled trial by @J_Salling_Quist and colleagues thelancet.com/journals/lanhl…
Signe S Torekov retweeted
#EASCongress2024 Adding exercise together w/ medications helps maintain healthy weight after medication. Living discussion also on calorie restriction and keto diets in Forum 2. I hope you didn't miss it!
@EASCongress @society_eas
Signe S Torekov retweeted
Fantastic talk, @STorekov !! Exploring ectopic fat and cardiometabolic diseases throughout life.
Signe S Torekov retweeted
Supported by a Distinguished Investigator grant, Professor Signe Torekov from the Department of Biomedical Sciences at University of Copenhagen will pioneer an innovative approach to prevent obesity in children. A study of 400 families dealing with obesity will consider how the weight and habits of parents affects their kids. Using AI to enhance physical activity levels, sleep and eating habits, the study hopes to change how we deal with childhood obesity. The ultimate goal is that healthier parents will lead to healthier children. The Distinguished Investigator grant is awarded as part of the Novo Nordisk Foundation’s Research Leader Programme, which aims to enable outstanding research while supporting the development of research leaders. Learn more here: novonordiskfonden.dk/en/news…
@STorekov @UCPH_Research
Signe S Torekov retweeted
This study underscores the multifaceted approach to obesity management, where the integration of exercise with pharmacotherapy, such as GLP-1 receptor agonists, enhances long-term weight maintenance outcomes. It's fascinating to see the positive effects persist even after a year without treatment. This adds a valuable piece to the puzzle of sustainable weight management strategies. For more in-depth analyses and a broader context on biomedical questions like this, I recommend checking out sciqst.com. SciQst leverages AI to generate comprehensive biomedical reviews, providing a one-stop solution for your biomedical inquiries, and it's free to use. #Medicine #ObesityManagement #WeightLoss
Signe S Torekov retweeted
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by 1 year no treatment
Addition of supervised exercise to obesity pharmacotherapy seems to improve healthy weight maintenance after treatment termination
thelancet.com/journals/eclin…
Signe S Torekov retweeted
Multiple reasons for weight loss and keeping the weight off @STorekov #Sportsmedisinskhøstkongres #Trondheim
Signe S Torekov retweeted
We are pleased to share the results of this human study thanks to a great collab. with @STorekov, which highlights endocannabinoid-related molecules as potential biomarkers of GLP-1R agonist efficacy in obesity.
link.springer.com/article/10….
Signe S Torekov retweeted
Better together-#Exercise and Liraglutide for maintenance of #weightloss and bone mineral density in PPL without #diabetes for 52 weeks @uni_copenhagen #EASD2023 @EASDnews @STorekov
Signe S Torekov retweeted
Kom og vær med som projektleder på vores spændende kæmpe projekt PRE-STORK med et fantastisk team. #forebyggelse af børneovervægt candidate.hr-manager.net/App…
Signe S Torekov retweeted
Happy to share our new paper published in Obesity.
The combination of exercise and liraglutide improved glucose tolerance, beta cell function, and postprandial glucagon response. onlinelibrary.wiley.com/doi/…
@chrisrjuhl @STorekov
@CTMetabUCPH @BiomedUCPH @UCPH_health @ObesitySociety
Signe S Torekov retweeted
Our new translational study on the hormone Neurotensin is out in @Metabolism! It shows that increased meal-induced #neurotensin response may predict successful maintenance of #weight loss @STorekov @BiomedUCPH @UCPH_Research @HoltJoachim metabolismjournal.com/articl…
Signe S Torekov retweeted
Health Evidence, the renowned provider of evidence-based information and resources related to public health, has mentioned our highly accessed systematic review (Anne-Ditte Termannsen et al., 2022): doi.org/10.1111/obr.13462
@Stenodiabetes
This Post is from an account that no longer exists. Learn more
Signe S Torekov retweeted
New study in Cardiovascular Diabetology @BioMedCentral shows that GLP-1 RA and #exercise can lower metabolic syndrome, abdominal #obesity, and #inflammation, potentially reducing the risk of future #CVD or #diabetes
@BiomedUCPH @STorekov @RasmusSandsdal
cardiab.biomedcentral.com/ar…
Signe S Torekov retweeted
Excited to announce that I recently started the MITO-DYS-IR project @CNMC_RH @BiomedUCPH
In collab with John Vissing, @STorekov, @stelar75, & @martamurgia, I will do studies in humans with mtDNA mutations to elucidate mitochondrial mechanisms driving muscle insulin resistance
Signe S Torekov retweeted
🧵Fasting GDF15 increased after 3 mo vigorous intensity exercise but not after 6 mo.
Thanks to all participants, staff and co-authors @ClemmensenC @BueKlein @Kristine_Faerch @KristineB_PhD, Mads Rosenkilde, Anne Sofie Gram, Anders Sjödin, @STorekov @BenteStall, Martin Bæk Blond